Your browser doesn't support javascript.
loading
Dacomitinib, a pan-inhibitor of ErbB receptors, suppresses growth and invasive capacity of chemoresistant ovarian carcinoma cells.
Momeny, Majid; Zarrinrad, Ghazaleh; Moghaddaskho, Farima; Poursheikhani, Arash; Sankanian, Ghazaleh; Zaghal, Azam; Mirshahvaladi, Shahab; Esmaeili, Fatemeh; Eyvani, Haniyeh; Barghi, Farinaz; Sabourinejad, Zahra; Alishahi, Zivar; Yousefi, Hassan; Ghasemi, Reza; Dardaei, Leila; Bashash, Davood; Chahardouli, Bahram; Dehpour, Ahmad R; Tavakkoly-Bazzaz, Javad; Alimoghaddam, Kamran; Ghavamzadeh, Ardeshir; Ghaffari, Seyed H.
Afiliación
  • Momeny M; Haematology/Oncology and Stem Cell Transplantation Research Centre, Shariati Hospital, School of Medicine, Tehran University of Medical Sciences, Tehran, Iran.
  • Zarrinrad G; Haematology/Oncology and Stem Cell Transplantation Research Centre, Shariati Hospital, School of Medicine, Tehran University of Medical Sciences, Tehran, Iran.
  • Moghaddaskho F; Haematology/Oncology and Stem Cell Transplantation Research Centre, Shariati Hospital, School of Medicine, Tehran University of Medical Sciences, Tehran, Iran.
  • Poursheikhani A; Department of Medical Genetics, School of Medicine, Tehran University of Medical Sciences, Tehran, Iran.
  • Sankanian G; Haematology/Oncology and Stem Cell Transplantation Research Centre, Shariati Hospital, School of Medicine, Tehran University of Medical Sciences, Tehran, Iran.
  • Zaghal A; Haematology/Oncology and Stem Cell Transplantation Research Centre, Shariati Hospital, School of Medicine, Tehran University of Medical Sciences, Tehran, Iran.
  • Mirshahvaladi S; Department of Molecular Systems Biology, Cell Science Research Centre, Royan Institute for Stem Cell Biology and Technology, ACECR, Tehran, Iran.
  • Esmaeili F; Department of Medical Genetics, School of Medicine, Tehran University of Medical Sciences, Tehran, Iran.
  • Eyvani H; Haematology/Oncology and Stem Cell Transplantation Research Centre, Shariati Hospital, School of Medicine, Tehran University of Medical Sciences, Tehran, Iran.
  • Barghi F; Haematology/Oncology and Stem Cell Transplantation Research Centre, Shariati Hospital, School of Medicine, Tehran University of Medical Sciences, Tehran, Iran.
  • Sabourinejad Z; Haematology/Oncology and Stem Cell Transplantation Research Centre, Shariati Hospital, School of Medicine, Tehran University of Medical Sciences, Tehran, Iran.
  • Alishahi Z; Department of Medical Genetics, School of Medicine, Tehran University of Medical Sciences, Tehran, Iran.
  • Yousefi H; Department of Medical Genetics, School of Medicine, Tehran University of Medical Sciences, Tehran, Iran.
  • Ghasemi R; Section of Stem Cell Biology, Division of Oncology, Department of Medicine, Washington University in Saint Louis, Saint Louis, MO, USA.
  • Dardaei L; Massachusetts General Hospital Cancer Centre, Charlestown, MA, USA.
  • Bashash D; Department of Haematology and Blood Banking, Faculty of Allied Medicine, Shahid Beheshti University of Medical Sciences, Tehran, Iran.
  • Chahardouli B; Haematology/Oncology and Stem Cell Transplantation Research Centre, Shariati Hospital, School of Medicine, Tehran University of Medical Sciences, Tehran, Iran.
  • Dehpour AR; Experimental Medicine Research Centre, Tehran University of Medical Sciences, Tehran, Iran.
  • Tavakkoly-Bazzaz J; Department of Pharmacology, School of Medicine, Tehran University of Medical Sciences, Tehran, Iran.
  • Alimoghaddam K; Department of Medical Genetics, School of Medicine, Tehran University of Medical Sciences, Tehran, Iran.
  • Ghavamzadeh A; Haematology/Oncology and Stem Cell Transplantation Research Centre, Shariati Hospital, School of Medicine, Tehran University of Medical Sciences, Tehran, Iran.
  • Ghaffari SH; Haematology/Oncology and Stem Cell Transplantation Research Centre, Shariati Hospital, School of Medicine, Tehran University of Medical Sciences, Tehran, Iran.
Sci Rep ; 7(1): 4204, 2017 06 23.
Article en En | MEDLINE | ID: mdl-28646172
Asunto(s)
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Neoplasias Ováricas / Resistencia a Antineoplásicos / Inhibidores de Proteínas Quinasas / Quinazolinonas / Receptores ErbB Tipo de estudio: Prognostic_studies Límite: Female / Humans Idioma: En Revista: Sci Rep Año: 2017 Tipo del documento: Article País de afiliación: Irán Pais de publicación: Reino Unido
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Neoplasias Ováricas / Resistencia a Antineoplásicos / Inhibidores de Proteínas Quinasas / Quinazolinonas / Receptores ErbB Tipo de estudio: Prognostic_studies Límite: Female / Humans Idioma: En Revista: Sci Rep Año: 2017 Tipo del documento: Article País de afiliación: Irán Pais de publicación: Reino Unido